Cabaletta Bio reports phase 1/2 data for autoimmune therapy

After a Tech Rout, Stock Funds Hold a 9.9% Gain for 2026

Dow Jones · Markets 16m ago

New House Democrats Set Their Priorities

Bloomberg · Markets Video 17m ago

Luxury Gyms Turn Fitness Into a Family Affair

Bloomberg · Markets Video 35m ago

Trump’s $1.5 Trillion Defense Budget to Be Blocked by Democrats

Bloomberg · Markets 35m ago

All eyes on Moog earnings amid record U.S. defense budget growth

Investing.com · News 37m ago

Moog earnings in focus: Can margins hold after blowout quarter?

Investing.com · News 38m ago

Organon earnings on deck as Sun Pharma merger awaits approval

Investing.com · News 39m ago

Teekay Tankers faces earnings test as shipping rates cool

Investing.com · News 40m ago

Pacira’s final earnings in spotlight before $1.65B sale

Investing.com · News 41m ago

France to join Ukraine talks in Abu Dhabi next week

Investing.com · Investing_news 47m ago